CytoMed Therapeutics Pte Ltd
Advancing Cellular Immunotherapy To Treat Cancer
CytoMed Therapeutics Pte Ltd is a business in biotech based in Singapore, founded in 2018.
Profile
Incorporated in 2018, CytoMed Therapeutics Pte Ltd (“CytoMed”), a spin-off from Singapore’s Agency for Science, Technology and Research (A*Star), focuses on translating its two patented technologies into allogeneic donor cell-based immuno-therapies centred on CAR gamma delta (γδ) T cells and induced pluripotent stem cell-derived γδ NK T cells, which could be safer and more accessible to patients. CytoMed was listed among the top 100 CAR T companies in the world.
CytoMed is a deep tech biotech company specialising in cell therapy. In particular, CytoMed’s cell therapy solution focuses on “off-the-shelf” donor allogeneic cellular therapeutics products which are not personalised and do not require patient matching for therapeutic use. CytoMed’s raw material is sourced from blood, umbilical cord or adipose tissue of healthy donor and clients.
The company sits in the biotech segment, where it competes on its core product or service.
Its base of operations is Singapore.
Its current recorded stage is Startup SG directory startup.
Recorded headcount: 1 - 10 employees.
| Sector | Biotech |
|---|---|
| Country | Singapore |
| Founded | 2018 |
| Employees | 1 - 10 |
| Stage | Startup SG directory startup |
Website: www.cytomed.sg
Create a free account